trastuzumab Archives - AudioMedica.com

Tagged: trastuzumab

- in Oncology
- — 16 Oct, 2007
Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer

Jose Baselga

Gordon McVie
REFERENCE: ABSTRACT 2030, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
JOSE BASELGA, Vall d’Hebron University Hospital, Barcelona
COMMENT: GORDON MCVIE, European Institute of Oncology, Milan
Neoadjuvant trastuzumab for patients with HER2-positive
…
Read more
- in AJO · ASCO · Oncology
- — 16 Jun, 2007
ASCO Audio Journal of Oncology in Advance – June 15th, 2007 – reporting from: ASCO Annual Meeting, Chicago, June 1-5, 2007

Christiane Kuhl

Julie Gralow
MRI Better Than Mammography for Detecting High-Grade Ductal Carcinoma In Situ?
REFERENCE: 1504, ASCO Annual Meeting Chicago June 1-5, 2007
CHRISTIANE KUHL, University of Bonn, Germany
COMMENT: JULIE GRALOW, University of Washington, Seattle
The ASCO meeting
…
Read more

in ASCO · Oncology
— 16 Feb, 2007

ASCO Audio Journal of Oncology in Advance – February 15th, 2007 – reporting from San Antonio Breast Cancer Symposium, December 13-17, 2007

Rachel Johnson

Terry Mamounas

William Gradishar

Withhold Trastuzumab in Low-Risk Patients with HER-2 Positive Breast Cancer?

REFERENCE: Abstract: 2090
RACHEL JOHNSON, Christie Hospital, Manchester
Some patients with HER-2 positive early breast cancer fare better if trastuzumab is withheld, according to

…

in AJO · Oncology
— 17 Jan, 2007

Audio Journal of Oncology in Advance – January 15th, 2007 – HERA Study Results Confirm Trastuzumab Benefit in HER2 Positive Early Breast Cancer

IAN SMITH, Royal Marsden Hospital, London

REFERENCE: Lancet 369:29
Confirmation of the life-extending benefits of trastuzumab adjuvant therapy for early breast cancer has been published recently in the Lancet. Ian Smith gave Peter Goodwin three-year follow up results from

…

in AJO · Oncology
— 2 Jan, 2007

Audio Journal of Oncology in Advance – January 1st, 2007 – Reporting from San Antonio Breast Cancer Symposium, December 14-17, 2006

Dennis Slamon

George Peoples

James Holland

Massimo Christofanilli

Trastuzumab: Mature Results in Early Breast Cancer Show Superiority

REFERENCE: San Antonio Breast Cancer Symposium 2006, Abstract: 52
DENNIS SLAMON, University of California, Los Angeles
Adjuvant therapy regimens containing trastuzumab have proved

…

in AJO · ASCO · Oncology
— 1 Dec, 2006

Audio Journal of Oncology in Advance – December 1st, 2006

Clifford Hudis

Mark Einstein

Tony Greco

James Berenson

Edward Ambinder

Breast Cancer: HER2 Still a Useful Target After Trastuzumab Resistance

REFERENCE: Chemotherapy Foundation Symposium XXIV 8-11 November 2006
CLIFFORD HUDIS, Memorial Sloan-Kettering Cancer Center, New York
COMMENT: EDWARD AMBINDER, Mount

…

in ASCO · Oncology
— 1 Nov, 2006

Audio Journal of Oncology in Advance – November 1st, 2006

David Cameron

Martine Piccart

Eric Van Cutsem

Jim Cassidy

Volker Heinemann

Lapatinib Better for Patients with HER2+ Refractory Breast Cancer Pre-treated with Chemotherapy and Trastuzumab

REFERENCE: ESMO 2006, Abstract: 141O
David Cameron, Western General Hospital, Edinburgh
COMMENT: Martine Piccart, Jules

…

in AJO · ASCO · Oncology
— 14 Oct, 2006

ASCO Audio Journal of Oncology in Advance – October 15th, 2006

Gordon McVie

Martine Piccart

Bella Kaufman

Jean-Yves Douillard

ESMO Congress Reviewed

GORDON MCVIE, European Institute of Oncology, Milan
In Istanbul, Gordon McVie gave his opinion about the achievements of the 2006 European Society for Medical Oncology Congress. He added his

…

in AJO · Oncology
— 14 Sep, 2006

ASCO Audio Journal of Oncology – September 15th, 2006

Robert Ozols

William See

Ruth Lupu

Improving on Standard Treatment in Ovarian Cancer: Have We Hit a Wall?

REFERENCE: Abstract 5002, 2006 ASCO Annual Meeting; N Engl J Med 2006, 354:34-43
ROBERT OZOLS, Fox Chase Cancer Center, Philadelphia
The combination

…